Lilly Covid drug, Vatican derivatives, UK mining corruption probe
FT News Briefing
00:00
Intro
This chapter covers Eli Lilly's urgent bid for COVID-19 antibody drug approval and its implications for public health. It also highlights ethical dilemmas surrounding the Vatican's financial decisions and a troubling investigation into suspicious witness deaths linked to corporate corruption.
Play episode from 00:00
Transcript
